Estimates Revisions BioMarin Pharmaceutical Inc.

Equities

Market Closed - Nasdaq Other stock markets 02:30:00 19/02/2026 am IST			5-day change	1st Jan Change
61.83 ^USD	+3.14%		+2.52%	+4.04%

18/02	Tarsus Pharmaceuticals, Inc. Appoints David E. I. Pyott to Its Board of Directors and Chairperson of Commercial Committee and as Member of Nominating Committee and Compensation Committee of the Board, Effective on February 18, 2026	CI
13/02	BioMarin Pharmaceutical Inc. Announces Closing of Private Offering of Senior Notes	CI

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	1m. Revenue rev.	1y. Revenue rev.	1y. EPS revision
	BIOMARIN PHARMACEUTICAL INC.
	REGENERON PHARMACEUTICALS, INC.
	UCB
	SAMSUNG BIOLOGICS CO.,LTD.
	CSL LIMITED
	BIOGEN INC.
	INCYTE CORPORATION
	INNOVENT BIOLOGICS, INC.
	MODERNA, INC.
	SWEDISH ORPHAN BIOVITRUM AB
	Average
	Weighted average by Cap.